Idiopathic erythema multiforme: Evidence of underlying Janus kinase–signal transducer and activator of transcription activation and successful treatment with tofacitinib

Detalles Bibliográficos
Autores principales: Damsky, William, King, Brett A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161778/
https://www.ncbi.nlm.nih.gov/pubmed/28004029
http://dx.doi.org/10.1016/j.jdcr.2016.10.009
_version_ 1782482109965795328
author Damsky, William
King, Brett A.
author_facet Damsky, William
King, Brett A.
author_sort Damsky, William
collection PubMed
description
format Online
Article
Text
id pubmed-5161778
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-51617782016-12-21 Idiopathic erythema multiforme: Evidence of underlying Janus kinase–signal transducer and activator of transcription activation and successful treatment with tofacitinib Damsky, William King, Brett A. JAAD Case Rep Case Report Elsevier 2016-12-07 /pmc/articles/PMC5161778/ /pubmed/28004029 http://dx.doi.org/10.1016/j.jdcr.2016.10.009 Text en © 2016 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Damsky, William
King, Brett A.
Idiopathic erythema multiforme: Evidence of underlying Janus kinase–signal transducer and activator of transcription activation and successful treatment with tofacitinib
title Idiopathic erythema multiforme: Evidence of underlying Janus kinase–signal transducer and activator of transcription activation and successful treatment with tofacitinib
title_full Idiopathic erythema multiforme: Evidence of underlying Janus kinase–signal transducer and activator of transcription activation and successful treatment with tofacitinib
title_fullStr Idiopathic erythema multiforme: Evidence of underlying Janus kinase–signal transducer and activator of transcription activation and successful treatment with tofacitinib
title_full_unstemmed Idiopathic erythema multiforme: Evidence of underlying Janus kinase–signal transducer and activator of transcription activation and successful treatment with tofacitinib
title_short Idiopathic erythema multiforme: Evidence of underlying Janus kinase–signal transducer and activator of transcription activation and successful treatment with tofacitinib
title_sort idiopathic erythema multiforme: evidence of underlying janus kinase–signal transducer and activator of transcription activation and successful treatment with tofacitinib
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161778/
https://www.ncbi.nlm.nih.gov/pubmed/28004029
http://dx.doi.org/10.1016/j.jdcr.2016.10.009
work_keys_str_mv AT damskywilliam idiopathicerythemamultiformeevidenceofunderlyingjanuskinasesignaltransducerandactivatoroftranscriptionactivationandsuccessfultreatmentwithtofacitinib
AT kingbretta idiopathicerythemamultiformeevidenceofunderlyingjanuskinasesignaltransducerandactivatoroftranscriptionactivationandsuccessfultreatmentwithtofacitinib

Ejemplares similares